Maurine D. Miner

机构：Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Fred Hutch Cancer Center, University of KwaZulu-Natal · ORCID：0000-0002-4637-1283

发表论文 49 篇 · 总被引 1705 次 · h-index 19

代表论文

• Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial (2023 · The Lancet HIV · 被引 33)
• Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region (2023 · Journal of Global Health · 被引 19)
• Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel (2022 · The Lancet HIV · 被引 19)
• Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial (2024 · The Lancet HIV · 被引 12)
• Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial (2024 · PLoS Medicine · 被引 9)
• Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial (2023 · Vaccine · 被引 8)